W. John Spicer

616 total citations
34 papers, 469 citations indexed

About

W. John Spicer is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, W. John Spicer has authored 34 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 9 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in W. John Spicer's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (9 papers) and Bacterial Identification and Susceptibility Testing (8 papers). W. John Spicer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (9 papers) and Bacterial Identification and Susceptibility Testing (8 papers). W. John Spicer collaborates with scholars based in Australia, France and United States. W. John Spicer's co-authors include Denis W. Spelman, Lisa L. Ioannides‐Demos, Allan J. McLean, A. J. McLean, Glenys Harrington, Bruce Davis, Marc Rabinov, Beverley Balkau, Donald Esmore and Julian A. Smith and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Thorax and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

W. John Spicer

34 papers receiving 440 citations

Peers

Countries citing papers authored by W. John Spicer

Since Specialization

Citations

This map shows the geographic impact of W. John Spicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. John Spicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. John Spicer more than expected).

Fields of papers citing papers by W. John Spicer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. John Spicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. John Spicer. The network helps show where W. John Spicer may publish in the future.

Co-authorship network of co-authors of W. John Spicer

This figure shows the co-authorship network connecting the top 25 collaborators of W. John Spicer. A scholar is included among the top collaborators of W. John Spicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. John Spicer. W. John Spicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Microbiology and Infectious Diseases: An Illustrated Colour Text 2007 ·Medical Entomology and Zoology ·W. John Spicer	1
2	Clinical bacteriology,mycology and Parasitology:an illustrated colour text 2000 ·Churchill Livingstone eBooks ·W. John Spicer	2
3	RISK FACTORS FOR SURGICAL WOUND INFECTION AND BACTERAEMIA FOLLOWING CORONARY ARTERY BYPASS SURGERY 2000 ·Australian and New Zealand Journal of Surgery ·Denis W. Spelman, Philip L. Russo, Glenys Harrington, Bruce Davis, Marc Rabinov, Julian A. Smith, W. John Spicer, Donald Esmore	78
4	Cephalosporin clinical concentration–time profile modelling and in-vitro bactericidal effects on Escherichia coli 1999 ·Journal of Antimicrobial Chemotherapy ·(unknown), Lisa L. Ioannides‐Demos, Lisa Liolios, Phillip Paull, W. John Spicer, Allan J. McLean	3
5	Changes in MIC Alter Responses of Pseudomonas aeruginosa to Tobramycin Exposure 1998 ·Antimicrobial Agents and Chemotherapy ·Lisa L. Ioannides‐Demos, Lisa Liolios, Paul Wood, W. John Spicer, A. J. McLean	7
6	Parvovirus B19 In HIV infection: A treatable cause of anemia 1996 ·Pathology ·Andrew Fuller, Len D Moaven, (unknown), W. John Spicer, (unknown), David J. Curtis, (unknown), Jennifer C. Doultree, Stephen Locarnini	20
7	Investigation of an Apparent Cluster of Klebsiella pneumoniae Bacteremias Using Random Amplified Polymorphic DNA Analysis 1996 ·Infection Control and Hospital Epidemiology ·James C. Hurley, E G Russell, Glenys Harrington, W. John Spicer	3
8	Aminoglycoside dosing: one, two or three times a day? 1996 ·The Medical Journal of Australia ·Allan J. McLean, Lisa L. Ioannides‐Demos, W. John Spicer, Nicholas Christophidis	5
9	Minimisation of aminoglycoside toxicity in patients with cystic fibrosis. 1996 ·Thorax ·Paul Wood, Lisa L. Ioannides‐Demos, (unknown), Trevor J. Williams, (unknown), W. John Spicer, (unknown), A. J. McLean	47
10	The usage and costs of health services for HIV infection in Australia 1995 ·AIDS ·Susan F. Hurley, (unknown), John B. Carlin, (unknown), David Evans, Patty Chondros, Jennifer Hoy, (unknown), W. John Spicer, (unknown), (unknown)	16
11	Bactericidal effect of gentamicin peak concentration provides a rationale for administration of bolus doses 1993 ·Journal of Antimicrobial Chemotherapy ·Allan J. McLean, Lisa L. Ioannides‐Demos, (unknown), (unknown), W. John Spicer	15
12	CASE REPORTS: INDIGENOUS INVASIVE AMOEBIASIS IN AUSTRALIA 1992 ·Australian and New Zealand Journal of Surgery ·(unknown), Denis W. Spelman, W. John Spicer	2
13	Dosage adjustment and clinical outcomes of long-term use of high-dose tobramycin in adult cystic fibrosis patients 1991 ·Journal of Antimicrobial Chemotherapy ·(unknown), Glenn Bowes, Lisa L. Ioannides‐Demos, W. John Spicer, (unknown), Denis W. Spelman, (unknown), Allan J. McLean	10
14	Case applications of a computer aided aminoglycoside therapeutic monitoring technique 1989 ·The Australian Journal of Hospital Pharmacy ·(unknown), (unknown), Paul M. Harrison, W. John Spicer, Denis W. Spelman, (unknown), (unknown), A. J. McLean	4
15	DESIGN AND TRIAL OF A METRONIDAZOLE LOADING DOSE REGIMEN FOR PATIENTS UNDERGOING EMERGENCY SURGERY 1989 ·Australian and New Zealand Journal of Surgery ·Lisa L. Ioannides‐Demos, (unknown), W. John Spicer, A. J. McLean	1
16	Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes 1989 ·The Medical Journal of Australia ·(unknown), Lisa L. Ioannides‐Demos, W. John Spicer, (unknown), Denis W. Spelman, (unknown), Allan J. McLean, John Shaw, Felix Bochner, Peter Brooks, John J. McNeil, Robert F.W. Moulds, Peter J. Ravenscroft, Anthony Smith	24
17	Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens 1988 ·Epidemiology and Infection ·Margaret Deighton, (unknown), W. John Spicer, Beverley Balkau	39
18	Campylobacter bacteraemia: a report of 10 cases 1986 ·The Medical Journal of Australia ·Denis W. Spelman, (unknown), (unknown), W. John Spicer, P. F. J. Ryan	27
19	Three strategies in the control of staphylococci including methicillin-resistant Staphylococcus aureus 1984 ·Journal of Hospital Infection ·W. John Spicer	33
20	Disposition and removal of metronidazole in patients undergoing haemodialysis 1983 ·European Journal of Clinical Pharmacology ·Andrew A. Somogyi, Norella Kong, J. Sabto, (unknown), W. John Spicer, A. J. McLean	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact